Summary.-The reproducibility of measurements of oestrogen-receptor activity has been examined in multiple specimens from a rabbit uterus, a rat mammary tumour and human breast tumours. The relationship between receptor concentration and tumour histology has also been investigated in 11 large primary tumours.
tumour and human breast tumours. The relationship between receptor concentration and tumour histology has also been investigated in 11 large primary tumours.
In the animal tissues, receptor measurements were relatively reproducible (coefficient of variance: wet wt. basis 16-17%, protein basis 16-21°0) but in human breast tumours receptor activity varied considerably (c.v.: wet wt. basis, 22-125%;
protein basis, 28-7200). In addition to these variations in receptor activity within tumours, there was a difference between tumours, as demonstrated by an analysis of variance (P<001).
In the 11 primary breast cancers selected for study, the level of receptor activity was related to menopausal status and the tumour content of the specimen.
We conclude that the receptor activity detected varies within a tumour and depends upon the tumour content of the biopsy specimen. Predictions based on precise quantitation of receptor concentrations may therefore necessitate replicate tumour sampling and correction for the fraction of non-tumour tissue in each sample.
CURRENTLY, the best index of the hormonal sensitivity of a breast cancer is the concentration of oestrogen-receptor protein in the cytoplasm of the tumour. (Folca, Glascock and Irvine 1961; Jensen et al., 1971; McGuire et al., 1975) . We have, therefore, investigated the reproducibility of receptor measurements and the role of morphological factors in determiining variations in receptor concentration.
MATERIALS AND METHODS
Tissues.-To examine the precision of the receptor assay, multiple (4-8) portions were cut at 0-40C, from each of 4 tissues selected for their apparent homogeneity. These tissues 'were the uterus from a non-pregnant rabbit, a rat mammary carcinoma (generated by the intragastric administration of 30 mg dimethylbenz(a)anthracene at 50 days of age) a large, cellular, intracanalicular fibroadenoma removed surgically from a 59-year-old woman, and a lymplh node which had been largely replaced by anaplastic breast carcinoma from a 75-year-old woman. Each portion of tissue was assayed for oestrogen-receptor activity.
To examine the reproducibility of receptor measurements in human breast cancer an(d relate this to morphology, 11 mastectomy specimens containing large, primary breast cancers were collected on ice. Each tumour wTas excised from the breast, measured and sectioned into 2-3 cubes. Each cube was divided into 2, one portion being used for histological examination, the other for oestrogen-receptor assay.
Oe8trogen-receptor activity was determined by the method of Hawkins, Hill and Freedman (1975) . A portion (160 >mg) of fat-free tumour was homogenized in tris buffer (0-25 M sucrose, 10 mM tris and 1 mM ethylene diamine tetra-acetate) at the rate of 100 mg/ml for 3 x 15 s, with intervals for cooling between periods of homogenization. (0, 10, 30, 50, 70, 90, 20,000 pg) were calculated from a Scatchard (1949) analysis of the data. The concentration of oestrogen receptors in each tumour sample was also expressed on a protein basis (PO, protein = fmol/mg extracted protein).
Protein concentration in each tumour extract was determined by the method of Lowry et al. (1951) . Extracts were diluted, and after reaction with Cu sulphate/FolinCiocalteau Reagent, the optical density at 750 nm was measured and compared with the values found for standard solutions of bovine serum albumin (0-100 mg/ml in water).
Histology.-Tumour specimens were fixed for 48 h in 100/ buffered formalin (pH 7-0) processed routinely and embedded in paraffin wax. Sections 5 ,um thick were stained with haematoxylin and eosin, and Gomori's aldehyde fuchsin.
In addition to the histological structure and differentiation of each tumour (Scarff and Torloni, 1968 ) a semi-quantitative assessment of the tumour content of each specimen was made by two observers. At the same time, the elastic tissue content of the tumour wras assessed. A simple 3-point scale w%-as used to grade the ratio of tumour: non-tumour tissue (1 low; 2 moderate; 3 high) and elastosis (0 not demonstrable, 1 small or moderate amount and 2 gross amount). Where there was disagreement between the two observers, slides were re-read and classified by agreement.
Statistical analysis-Since the levels of receptor activity found in breast tumours are not normally distributed, a logarithmic function of receptor concentration, loglo (10 PO + 1) was used for the analysis.
The sources of difference in receptor concentrations between specimens from the 11 primary tumours were examined by an analysis of variance for nested data (Snedecor and Cochran, 1971 ) and assay precision was calculated as the coefficient of variation from duplicate determinations (Snedecor, 1952) .
Mean oestrogen-receptor concentration was assessed primarily in relation to tumour content by the Rank Correlation Test (Kendall, 1975) . No attempt was made to study partial rank correlations for which adequate significance tests have not been devised.
RESULTS

Apparently homogeneous tissues
The precisioni of measurements of receptor concentration (PO) in two superficially homogeneous animal tissues (uterus and mammary carcinoma) was 16-1700 on a wet-wt basis (Table I ). The mean In contrast to these animal tissues, the precision of the measurements in human tumours was rather low, being 650o in the giant fibroadenoma and 58% in the secondary breast cancer, on a wet-wt basis (Table II) . The mean (lissociation constants in these tissues were 0-37x 10-10 molar with a precision of 9.2% in the fibroadenoma and I1 7 x 10-10 molar with a precision of 490o in the secondary cancer, the latter value including an abnormally high value (2.5 x 10-10 molar for Specimen E, Table 11 ).
Expression of these results on a protein basis (Tables I and II) did not correct for the apparent variation in receptor levels between specimens from the same tumour.
Primary breast cancers
The results of oestrogen-receptor assays in multiple specimens from the 11 primary breast cancers are given in Table III Table VI ). The dissociation constants for all the specimens were in the range of 0 11-0 99 x 10-10 molar and averaged 0 52+0 24x ]0-10 molar for premenopausal and 0 40±0 19 x 1 o-10 for postmenopausal women. In an analysis of variance (Table IV) Using the Rank Correlation Test, a significant, positive correlation (P<0.02) was found between mean tumour content and the mean receptor activity for the same tumour. This is illustrated in the Figure, which shows the individual result for each of the 27 specimens taken from the 11 primary tumours, though the Rank Correlation Test was performed on the 11 mean values (Table VI) .
DISCUSSION
It is generally held that biological assays for clinical use should have a precision (coefficient of variation) of better than 15% (Whitby, Mitchell and Moss, 1967) . We found that the precision of the measurement of oestrogen-receptor concentrations in two relatively homogeneous tissues obtained from animals was 16-170% (wet wt basis). This compares well with the 16% reported by Braunsberg (1975) who used human tumours which, to ensure homogeneity, were each minced and mixed before assay in duplicate.
When human tumours (a secondary breast cancer, a giant fibroadenoma and 11 primary breast cancers) were examined, 24 the precision of the measurement of receptor concentrations fell to 22-125% (wet wt basis) and that of dissociation constant to 46-47%. Although this degree of imprecision is exaggerated for two of the 36 specimens studied (see footnotes to Tables II and III) which had high receptor concentrations barely saturable at the levels of oestrogen used in the assay (100 pg), considerable differences in receptor activity were observed between adjacent specimens in 11/13 tumours. This finding is in agreement with the earlier reports of Braunsberg (1975) and of Leclereq et al., (1975) .
Expression of the receptor concentration on a protein basis did not improve the precision of measurements, findings in agreement with those of Rosen et al. (1975) and Jensen et al. (1975) . However, the methods used for preparing tumour extracts differed from those of Leclereq et al. (1973) and of Teulings et al. (1975) Rosen et al. (1975) , who noted that receptor concentration was significantly related also to histological type of tumour.
Two important observations emerge from this work. Firstly, we conclude that the quantitation of oestrogen-receptor activity based on a single sample of a tumour is imprecise, and that if critical levels of receptor activity are to be used to select patients for treatment by endocrine means, such assays are of little value. Secondly, we have presented evidence that the variation in receptor activity between tumours is partly due to variations in tumour content. The use of receptor measurements for predicting response must, therefore, be considered in conjunction with some assessment of the proportion of tumour present in the biopsy specimen assayed.
In addition to the two deficiencies reported above, two further limitations apply to most of the methods currently employed in this and other laboratories for the estimation of oestrogen-receptor activity: in general, assays (i) only measure available (empty) receptor sites, and (ii) are susceptible to interference by plasma components (Hawkins, Scott and Yap, 1977) . Until oestrogen-receptor methodology is iniproved to take all these 4 deficiencies into account, with some standardization of assay conditions such as sensitivity, correction for non-specific binding and quality-control, the relationship between tumour receptor concentration and response to endocrine therapy cannot be clearly established.
